Viewing Study NCT02729961


Ignite Creation Date: 2025-12-24 @ 12:10 PM
Ignite Modification Date: 2026-04-22 @ 7:49 PM
Study NCT ID: NCT02729961
Status: WITHDRAWN
Last Update Posted: 2019-10-10
First Post: 2016-03-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Ceritinib With Brentuximab Vedotin in Treating Patients With ALK-Positive Anaplastic Large Cell Lymphoma
Sponsor: University of Washington
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module